China Animal Husbandry Industry Co Ltd
SSE:600195
Net Margin
China Animal Husbandry Industry Co Ltd
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| CN |
|
China Animal Husbandry Industry Co Ltd
SSE:600195
|
6.5B CNY |
2%
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
782.6B USD |
24%
|
|
| UK |
|
Dechra Pharmaceuticals PLC
LSE:DPH
|
440.4B GBP |
-4%
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
399.2B USD |
16%
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
2.1T DKK |
35%
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
231.6B CHF |
20%
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
198.1B CHF |
23%
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
174.5B GBP |
13%
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
227.3B USD |
27%
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
167.6B USD |
-126%
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
143B USD |
13%
|
China Animal Husbandry Industry Co Ltd
Glance View
China Animal Husbandry Industry Co Ltd. (CAHI) is a compelling narrative of innovation and integration in the agricultural sector, deeply rooted in its mission to uphold food security and safety. As an integral part of the animal husbandry landscape, CAHI wields a strategic mix of agricultural science and technology, producing a diverse portfolio of products ranging from animal feed to veterinary drugs and vaccines. This vertically integrated approach allows the company to control and optimize each stage of the production process. By doing so, CAHI not only ensures the quality and reliability of its products but also maximizes its operational efficiencies. The company's facilities operate at the forefront of technology, leveraging advancements to develop solutions that boost livestock health and farmer productivity, addressing the growing food demand in China and internationally. Revenue streams for CAHI are robust, stemming from its diversified product lineup designed to cater to the entire spectrum of the animal farming industry. The company monetizes its expertise through the sale of feed additives, veterinary pharmaceuticals, and biological products, which are crucial inputs for livestock farmers aiming to enhance productivity and safeguard their herds against diseases. Beyond just selling products, CAHI's value proposition includes extensive after-sales services and technical support, differentiating itself from competitors. By continuously investing in research and development, CAHI sustains its growth trajectory, adapting to regulatory shifts and consumer preferences while positioning itself as a leader in the global market for animal husbandry solutions. This combination of innovation, integration, and customer-focused services anchors CAHI's business model and drives its profitability.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on China Animal Husbandry Industry Co Ltd's most recent financial statements, the company has Net Margin of 1.6%.
You don't have any saved screeners yet